Complete Filing Data
Shuttle Pharmaceuticals Holdings, Inc. reported Stockholders Equity of $2.25 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Shuttle Pharmaceuticals Holdings, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Income Loss | -$11.7M | -$9.1M | -$6.6M | -$3.0M | -$1.2M |
| Research And Development Expense | $4.1M | $3.6M | $3.5M | $1.1M | $1.0M |
| Operating Income Loss | -$11.9M | -$7.7M | -$5.9M | -$2.6M | -$1.7M |
| Operating Expenses | $11.9M | $7.7M | $5.9M | $2.6M | $1.7M |
| Nonoperating Income Expense | $195.2K | -$1.4M | -$700.3K | -$474.2K | $590.9K |
| General And Administrative Expense | $5.7M | $1.4M | $1.0M | $538.8K | $36.5K |
| Net Income Loss Available To Common Stockholders Basic | -$6.6M | -$3.1M | -$1.3M | ||
| Marketable Securities Gain Loss Excluding Other Than Temporary Impairments | $71.6K | ||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$6.6M | -$3.0M | -$1.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$2.3M | -$3.7M | -$3.1M | -$3.8M | -$2.0M | -$1.7M | -$1.8M | -$2.2M | -$975.1K | -$998.4K | -$597.3K | -$681.8K | -$217.0K | -$346.8K | -$129.3K |
| Research And Development Expense | $943.5K | $1.0M | $1.6M | $1.4M | $645.7K | $586.1K | $1.0M | $839.7K | $921.8K | $669.0K | $83.9K | $295.9K | $187.0K | ||
| Operating Income Loss | -$2.3M | -$3.9M | -$3.0M | -$3.1M | -$1.5M | -$1.4M | -$1.6M | -$1.5M | -$1.5M | -$821.5K | -$353.6K | -$638.4K | -$242.1K | ||
| Operating Expenses | $2.3M | $3.9M | $3.0M | $3.1M | $1.5M | $1.4M | $1.6M | $1.5M | $1.5M | $821.5K | $353.6K | $638.4K | $242.1K | ||
| Nonoperating Income Expense | -$80.4K | $203.9K | -$101.8K | -$732.5K | -$548.6K | -$346.2K | -$193.6K | -$718.7K | $569.7K | -$177.0K | -$243.6K | -$43.4K | $25.2K | ||
| General And Administrative Expense | $886.1K | $2.3M | $596.9K | $329.0K | $310.0K | $324.6K | $265.6K | $209.3K | $255.4K | $81.9K | $9.1K | $13.8K | $6.4K | ||
| Net Income Loss Available To Common Stockholders Basic | -$1.8M | -$2.2M | -$975.1K | -$1.0M | -$623.0K | -$707.6K | -$242.7K | ||||||||
| Marketable Securities Gain Loss Excluding Other Than Temporary Impairments | -$42.9K | -$28.0K | -$706.00 | $9.6K | -$26.5K | $38.1K | |||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$1.8M | -$975.1K | -$998.4K | -$681.8K | -$217.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stockholders Equity | $2.3M | $709.2K | $4.1M | $7.7M | -$1.6M | -$1.7M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $334.0K | $1.9M | $2.6M | $8.4M | $504.7K | $117.2K |
| Retained Earnings Accumulated Deficit | -$46.3M | -$34.6M | -$25.4M | -$8.9M | -$5.8M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$1.6M | -$656.3K | -$5.8M | $7.9M | $387.6K | |
| Loss On Settlement Of Convertible Debt | $833.5K | $477.2K | ||||
| Amortization Of Debt Discount Premium | $62.0K | $1.1M | $2.1M | $885.5K | $3.4K | |
| Property Plant And Equipment Net | $17.3K | $19.4K | $24.8K | $12.6K | $18.6K | |
| Operating Lease Right Of Use Asset | $102.4K | $276.0K | $333.9K | $56.1K | $117.0K | |
| Operating Lease Liability Current | $77.2K | $60.9K | $52.5K | $62.8K | $66.9K | |
| Liabilities Current | $8.0M | $1.5M | $1.0M | $975.7K | $2.2M | |
| Liabilities And Stockholders Equity | $10.5M | $2.5M | $6.0M | $8.7M | $651.6K | |
| Liabilities | $8.2M | $1.8M | $1.9M | $975.7K | $2.3M | |
| Common Stock Value | $20.00 | $2.00 | $20.00 | $136.00 | $93.00 | |
| Assets Current | $502.9K | $2.2M | $5.6M | $8.6M | $509.6K | |
| Assets | $10.5M | $2.5M | $6.0M | $8.7M | $651.6K | |
| Preferred Stock Liquidation Preference | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | |
| Cash And Cash Equivalents At Carrying Value | $334.0K | $1.9M | $2.6M | $8.4M | $504.7K | |
| Gain Loss On Sale Of Investments | $28.6K | $5.0K | ||||
| Operating Lease Liability Noncurrent | $155.0K | $238.1K | $304.1K | $62.4K | ||
| Derivative Liabilities Noncurrent | $99.7K | $25.3K | $414.5K | |||
| Stock Issued During Period Value Conversion Of Accrued Interest And Principal | $2.7M | |||||
| Accrued Interest Settled With Common Stock | $54.7K | $294.9K | ||||
| Repayments Of Related Party Debt | $190.3K | $59.7K | $685.5K | $50.0K | ||
| Preferred Stock Dividends Income Statement Impact | $71.0K | $103.1K | ||||
| Dividends Preferred Stock | $71.0K | $103.1K | ||||
| Common Stock Issued For Settlement Of Debt | $1.9M | $2.7M | $588.5K | |||
| Interest Receivable Current | $14.9K | |||||
| Repayments Of Convertible Debt | $846.8K | $334.4K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $1.4M | $3.6M | $3.3M | -$1.3M | $801.4K | $2.8M | $5.6M | $6.9M | $6.9M | $8.4M | -$2.3M | -$1.8M | -$2.1M | -$2.0M | -$1.7M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $2.1M | $4.8M | $4.5M | $156.7K | $695.6K | $1.4M | $3.9M | $5.4M | $7.2M | $9.1M | $50.4K | $405.9K | $145.0K | ||
| Retained Earnings Accumulated Deficit | -$43.7M | -$41.3M | -$37.6M | -$33.0M | -$29.2M | -$17.2M | -$13.8M | -$12.1M | -$9.9M | -$8.1M | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $2.6M | -$1.2M | -$1.2M | -$98.9K | |||||||||||
| Loss On Settlement Of Convertible Debt | $762.2K | $71.3K | $43.4K | $415.6K | $18.3K | ||||||||||
| Amortization Of Debt Discount Premium | $6.5K | $445.5K | $567.3K | $129.6K | |||||||||||
| Property Plant And Equipment Net | $18.3K | $19.3K | $18.4K | $21.2K | $22.0K | $22.9K | $26.8K | $9.6K | $11.1K | $14.1K | |||||
| Operating Lease Right Of Use Asset | $228.4K | $244.7K | $260.6K | $291.1K | $305.7K | $320.0K | $353.4K | $384.1K | $39.8K | $72.0K | |||||
| Operating Lease Liability Current | $74.5K | $71.9K | $63.2K | $58.7K | $62.1K | $54.6K | $61.0K | $61.0K | $44.6K | $73.7K | |||||
| Liabilities Current | $2.0M | $1.7M | $1.8M | $1.7M | $1.4M | $1.5M | $810.4K | $493.7K | $1.4M | $970.5K | |||||
| Liabilities And Stockholders Equity | $3.5M | $5.5M | $5.3M | $673.6K | $2.8M | $4.8M | $7.4M | $8.8M | $10.4M | $9.4M | |||||
| Liabilities | $2.1M | $1.9M | $2.0M | $2.0M | $2.0M | $2.0M | $1.8M | $1.9M | $3.5M | $977.1K | |||||
| Common Stock Value | $13.00 | $11.00 | $63.00 | $29.00 | $21.00 | $168.00 | $160.00 | $155.00 | $137.00 | $136.00 | |||||
| Assets Current | $3.3M | $5.2M | $5.0M | $361.4K | $2.5M | $4.4M | $7.0M | $8.4M | $10.4M | $9.3M | |||||
| Assets | $3.5M | $5.5M | $5.3M | $673.6K | $2.8M | $4.8M | $7.4M | $8.8M | $10.4M | $9.4M | |||||
| Preferred Stock Liquidation Preference | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | ||||||
| Cash And Cash Equivalents At Carrying Value | $2.1M | $4.8M | $4.5M | $156.7K | $695.6K | $1.4M | $3.9M | $5.4M | $7.2M | ||||||
| Gain Loss On Sale Of Investments | $56.4K | $39.7K | $4.0K | $1.7K | |||||||||||
| Operating Lease Liability Noncurrent | $175.3K | $195.2K | $220.1K | $255.6K | $267.0K | $288.6K | $308.4K | $329.8K | $751.7K | $6.7K | |||||
| Derivative Liabilities Noncurrent | $8.5K | $11.0K | $22.6K | $74.1K | $359.9K | $214.6K | $512.8K | $955.7K | $1.4M | ||||||
| Stock Issued During Period Value Conversion Of Accrued Interest And Principal | $1.6M | $325.3K | $2.2M | $104.5K | |||||||||||
| Accrued Interest Settled With Common Stock | $18.8K | $20.1K | |||||||||||||
| Repayments Of Related Party Debt | $61.5K | $546.2K | |||||||||||||
| Preferred Stock Dividends Income Statement Impact | $19.5K | $25.8K | $25.8K | $25.8K | |||||||||||
| Dividends Preferred Stock | $19.5K | $25.8K | $25.8K | $25.8K | $25.8K | $25.8K | |||||||||
| Common Stock Issued For Settlement Of Debt | $325.3K | $104.5K | |||||||||||||
| Interest Receivable Current | $4.00 | $7.2K | $12.0K | $12.4K | $7.0K | $7.0K | |||||||||
| Repayments Of Convertible Debt |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Share Based Compensation | $933.0K | $259.7K | $182.0K | $404.0K | $910.1K |
| Net Cash Provided By Used In Operating Activities | -$9.5M | -$7.3M | -$5.6M | -$2.7M | -$300.3K |
| Net Cash Provided By Used In Financing Activities | $11.0M | $3.8M | $2.6M | $10.6M | $687.9K |
| Increase Decrease In Operating Lease Liability | -$2.5K | $286.00 | $16.0K | -$5.7K | -$58.5K |
| Increase Decrease In Prepaid Expense | -$121.9K | $176.3K | -$46.7K | $156.3K | -$7.7K |
| Increase Decrease In Interest Payable Net | -$15.1K | $110.5K | -$13.2K | $160.00 | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $423.0K | $313.7K | $166.1K | -$382.9K | |
| Increase Decrease In Due To Related Parties Current | -$446.00 | -$12.1K | $12.5K | ||
| Increase Decrease In Accrued Interest Payable Related Parties | -$1.8K | $1.8K | -$98.1K | $51.2K | |
| Net Cash Provided By Used In Investing Activities | -$3.1M | $2.9M | -$2.8M | ||
| Increase Decrease In Accrued Interest Receivable Net | -$14.9K | $14.9K | |||
| Payments To Acquire Marketable Securities | $43.6K | $3.0M | |||
| Proceeds From Convertible Debt | $790.0K | $3.9M | $600.7K | ||
| Proceeds From Sale And Maturity Of Marketable Securities | $3.0M | $187.9K | |||
| Proceeds From Related Party Debt | $250.0K | $50.0K | $120.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Share Based Compensation | $537.0K | $111.4K | $8.3K | $166.5K |
| Net Cash Provided By Used In Operating Activities | -$2.5M | -$1.2M | -$1.3M | -$624.6K |
| Net Cash Provided By Used In Financing Activities | $5.1M | -$40.0K | $3.0M | $525.7K |
| Increase Decrease In Operating Lease Liability | -$209.00 | $466.00 | -$1.9K | -$1.3K |
| Increase Decrease In Prepaid Expense | $156.0K | $15.2K | $42.7K | $15.7K |
| Increase Decrease In Interest Payable Net | $33.2K | $116.1K | $16.0K | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $79.5K | $23.2K | $330.7K | -$137.1K |
| Increase Decrease In Due To Related Parties Current | -$446.00 | -$12.5K | ||
| Increase Decrease In Accrued Interest Payable Related Parties | -$577.00 | -$74.8K | $10.5K | |
| Net Cash Provided By Used In Investing Activities | $101.3K | -$3.0M | ||
| Increase Decrease In Accrued Interest Receivable Net | -$2.9K | $7.0K | ||
| Payments To Acquire Marketable Securities | $18.7K | $3.0M | ||
| Proceeds From Convertible Debt | $3.9M | $525.7K | ||
| Proceeds From Sale And Maturity Of Marketable Securities | $120.0K | |||
| Proceeds From Related Party Debt |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 1.6M | 114.8K | 1.9M | 10.4M | 9.3M |
| Earnings Per Share Basic | $-7.16 | $-79.65 | $-3.53 | $-0.29 | $-0.12 |
| Earnings Per Share Diluted | $-7.16 | $-82.60 | $-3.53 | $-0.29 | |
| Weighted Average Number Of Diluted Shares Outstanding | 1.6M | 115.5K | 1.9M | 10.4M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 2.0M | 163.1K | 2.0M | 13.6M | 9.3M |
| Common Stock Shares Issued | 2.0M | 163.1K | 2.0M | 13.6M | 9.3M |
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M |
| Preferred Stock Shares Authorized | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 1.2K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 2.2M | 1.1M | 10.0M | 95.0K | 84.2K | 2.1M | 2.0M | 1.8M | 13.6M | 10.2M | 9.3M | 9.3M | 9.3M |
| Earnings Per Share Basic | $-1.05 | $-3.29 | $-0.30 | $-39.83 | $-24.12 | $-0.83 | $-0.91 | $-1.23 | $-0.07 | $-0.10 | $-0.06 | $-0.07 | $-0.02 |
| Earnings Per Share Diluted | $-1.05 | $-3.29 | $-0.30 | $-39.83 | $-24.12 | $-0.83 | $-0.91 | $-1.23 | $-0.07 | $-0.10 | $-0.06 | ||
| Weighted Average Number Of Diluted Shares Outstanding | 2.2M | 1.1M | 10.0M | 95.0K | 84.2K | 2.1M | 2.0M | 1.8M | 13.6M | 9.3M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Shares Outstanding | 1.2M | 1.1M | 6.4M | 2.9M | 2.1M | 16.8M | 16.0M | 15.5M | 13.7M | 13.6M | |||
| Common Stock Shares Issued | 1.2M | 1.1M | 6.4M | 2.9M | 2.1M | 16.8M | 16.0M | 15.5M | 13.7M | 13.6M | |||
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | |||
| Preferred Stock Shares Authorized | 800.0K | 800.0K | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Legal Fees | $2.2M | $2.7M | $1.3M | $866.8K | $684.7K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $933.0K | $259.7K | $182.0K | $404.0K | $420.0K |
| Derivative Gain Loss On Derivative Net | -$74.4K | $555.8K | $2.2M | $94.0K | |
| Investment Income Interest | $1.1K | $38.1K | $79.1K | ||
| Depreciation | $5.5K | $6.8K | $6.0K | $6.2K | |
| Additional Paid In Capital | $48.6M | $35.3M | $29.5M | $16.6M | |
| Interest Paid Net | $125.3K | $86.6K | $164.8K | $39.2K | $293.00 |
| Warrants Issuance Fees | $0.00 | $8.7K | $0.00 | ||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $1.5K | $90.8K | $412.2K | $407.3K | |
| Prepaid Expense Current | $114.5K | $161.1K | $4.9K | ||
| Fair Value Adjustment Of Warrants | -$94.0K | -$579.1K | |||
| Stock Issued During Period Value New Issues | $5.0M | $3.6M | $10.0M | ||
| Stock Issued During Period Value Conversion Of Convertible Securities | $1.9M | $588.5K | |||
| Finance Fee | $152.7K | $104.2K | |||
| Warrants Issued For Financing Fees | $90.8K | $412.2K | |||
| Stock Issued During Period Shares Conversion Of Convertible Securities | 2.4M | 839.00 | |||
| Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Legal Fees | $437.4K | $538.5K | $780.4K | $1.3M | $526.9K | $474.1K | $288.4K | $416.7K | $367.6K | $70.6K | $260.7K | $328.7K | $48.7K | ||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $134.3K | $46.9K | $537.0K | $45.3K | $71.2K | $111.4K | $37.6K | $49.5K | $8.3K | $23.7K | $166.5K | $166.5K | |||||
| Derivative Gain Loss On Derivative Net | $2.4K | $11.7K | $2.6K | $286.3K | -$143.8K | $197.9K | $442.9K | $434.3K | $1.2M | $112.8K | -$58.4K | $39.7K | |||||
| Investment Income Interest | $486.00 | $81.00 | $2.5K | $14.2K | $21.5K | $20.8K | $19.3K | $16.7K | |||||||||
| Depreciation | $1.0K | $1.9K | $1.5K | $1.5K | |||||||||||||
| Additional Paid In Capital | $45.1M | $44.9M | $40.9M | $31.7M | $30.0M | $20.0M | $19.5M | $19.0M | $16.8M | ||||||||
| Interest Paid Net | $36.2K | $79.0K | |||||||||||||||
| Warrants Issuance Fees | $0.00 | $8.7K | |||||||||||||||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $1.5K | $90.8K | $92.6K | $319.6K | |||||||||||||
| Prepaid Expense Current | $374.2K | $446.8K | $290.8K | $103.0K | $139.5K | $129.6K | $170.1K | $78.9K | $203.8K | ||||||||
| Fair Value Adjustment Of Warrants | -$112.8K | $16.7K | $26.7K | ||||||||||||||
| Stock Issued During Period Value New Issues | $3.9M | $5.0M | $10.0M | ||||||||||||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $68.3K | $53.5K | $1.6M | $429.3K | $2.2M | $104.5K | $588.5K | ||||||||||
| Finance Fee | $104.2K | ||||||||||||||||
| Warrants Issued For Financing Fees | $90.8K | ||||||||||||||||
| Stock Issued During Period Shares Conversion Of Convertible Securities | 502.1K | 1.8M | 0.00 | 839.00 | |||||||||||||
| Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | $23.7K | $166.5K | $166.5K | $122.5K | $122.5K | $122.5K |
Most recent annual filing with the SEC: March 31, 2026
Data sourced from SEC EDGAR public filings as of August 8, 2026.